Cascade Pharmaceuticals is a clinical-stage biopharmaceutical company focused on unmet medical needs in metabolic diseases and inflammation. It specializes in early discovery, drug development, and eventual commercialization with an emphasis on nuclear receptors and G protein–coupled receptors (GPCRs). Based in Shanghai, China, the company aims to become a leading force in global novel drug development, leveraging decades of experience in medicinal chemistry, pharmacology, and preclinical research across SPF animal facilities and related platforms.
No recent news for this company.